Costing
Given the uncertainties in estimating the eligible population, the financial implications of introducing NAAT are uncertain. However, as NAAT is proposed to be used as an add-on test, net costs to the MBS are implied. Estimates presented in the assessment ($3.7 million to $4.3 million over the 5-year period) are likely to represent the upper limits of proposed use, as all assumptions regarding the eligible population are likely to be overestimated. The financial implications are most sensitive to changes in the cost per test. While benefits associated with reduced transmissions may be expected, these have not been quantified.
As NAAT is currently being used (the extent of which is uncertain), some shifting of costs from the states to the federal health budget is anticipated, and so the net financial implications to the Australian healthcare system are likely to be less than the net cost of introducing NAAT to the MBS.
Appendix Health Expert Standing Panel and Assessment Group
Dostları ilə paylaş: |
